Clinical Trial Update: Pimavanserin for Sleep in Parkinson Disease [EARLY_Phase 1]

View source ↗

Summary

A clinical trial evaluating pimavanserin for sleep disturbances in Parkinson's disease was withdrawn (early-phase 1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Parkinson Disease | EARLY_Phase 1 | Status: WITHDRAWN